9 nominees · 5 ballot items.
Elect nine directors; Advisory say-on-pay vote to approve fiscal 2025 executive compensation; Approve increase of 2,000,000 shares for 2008 Stock Option and Incentive Plan; Approve increase of 900,000 shares for 1991 Employee Stock Purchase Plan (ESPP); Ratify Deloitte & Touche LLP as independent registered public accounting firm for fiscal 2026.
Elect nine directors to serve until the 2027 Annual Meeting.
Advisory vote to approve the fiscal 2025 compensation of the named executive officers.
The proposal asks stockholders to approve, on an advisory basis, the Company’s fiscal 2025 executive compensation as disclosed in the proxy, reflecting Progress’s pay-for-performance philosophy. Management seeks approval to validate its compensation program design: a mix of base salary, annual cash bonuses tied 100% to difficult financial metrics, and long-term equity (50% PSUs tied to 3-year TSR and cumulative operating income, 30% RSUs, 20% options). The Compensation Committee emphasizes alignment with stockholders, retention, and recruiting, noting strong fiscal 2025 performance and a 93% prior say-on-pay approval; it retains an independent consultant and implements clawback and stock ownership policies. The board recommends FOR, arguing the programs are market-competitive, link pay to multi-year performance, and include governance safeguards (caps, no hedging, independent review). Risks include concentrated reliance on non-GAAP metrics, integration effects from acquisitions on targets, and potential misalignment if relative TSR underperforms; however, management notes adjustments for acquisitions and multi-metric structures to mitigate gaming. The net effect is the board endorses the proposal as reinforcing pay-for-performance alignment and continuity of the Total Growth Strategy.
Approve amendment to increase shares reserved under the 2008 Plan by 2,000,000 shares and make other immaterial administrative edits.
Management asks shareholders to approve an amendment increasing the 2008 Plan share reserve by 2,000,000 shares (to provide roughly a one-year runway given current grant practices). The company argues the reserve supports its compensation program to attract, retain, and incentivize employees, including post-acquisition integration and new hiring; the board approved the A&R 2008 Plan and recommends FOR. Key plan features: no evergreen replenishment, conversion rates for full-value awards (2.25 prior to May 9, 2024; 1.5 thereafter), limits on repricing without shareholder approval, and sale-event acceleration/assumption provisions. The board assessed dilution metrics (requested additional shares represent ~4.75% of outstanding shares), overhang (basic diluted 23.66%), burn rate (3-year average net 5.12%), and believes the request is reasonable. Considerations for an analyst include potential dilution from continued heavy use of full-value awards and acquisitions, the company's rationale tying equity to Total Growth Strategy, governance safeguards, and historical high usage of awards; the proposal is routine but material to compensation and capital structure, and the board’s rationale and metrics support an affirmative vote while investors should monitor post-approval grant practices and dilution.
Approve amendment to increase shares reserved under the ESPP by 900,000 shares.
Management requests shareholder approval to add 900,000 shares to the ESPP reserve to support employee participation and retention. The ESPP offers 85% purchase price of the lower of offering start or exercise date market price, overlapping 27-month offering periods with quarterly purchase dates, and typical Section 423 tax-favored terms. The board recommends FOR, noting ~1,526 employees participating as of Dec 14, 2025, and that the increase will allow continued broad-based employee ownership. For analysts, relevant considerations include dilution (900,000 shares represent ~2.14% of outstanding shares), current participation rates, and administrative structure; the proposal is standard for broad-based employee ownership programs and includes customary tax and eligibility constraints.
Ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026.
The Audit Committee seeks ratification of Deloitte as the company’s independent auditor for fiscal 2026, citing institutional knowledge, audit quality, efficient fee structure, and rotation of the lead partner every five years to support independence. The Audit Committee recommends FOR and notes aggregate audit fees ($2.65M for 2025) and pre-approval policies for non-audit services. This is a routine auditor ratification; the board’s continued use of Deloitte is justified by continuity and oversight processes, but investors should note tenure and the committee’s oversight practices.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.59% | 4,876,909 | $125M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.15% | 3,430,715 | $88M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.58% | 1,928,640 | $49M |
| 4 | STATE STREET CORP | 4.19% | 1,761,009 | $45M |
| 5 | BlackRock, Inc. | 3.22% | 1,355,817 | $35M |
| 6 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.90% | 1,221,647 | $31M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 2.71% | 1,140,111 | $29M |
| 8 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2.54% | 1,070,327 | $27M |
| 9 | Boston Trust Walden Corp | 2.52% | 1,060,138 | $27M |
| 10 | LSV ASSET MANAGEMENT | 2.35% | 988,400 | $25M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.